Celldex Posts Wider Q3 Loss

(RTTNews) - Celldex Therapeutics, Inc. (CLDX) reported a net loss of $28.1 million or $0.31 per share for the third quarter, compared to a net loss of $23.1 million or $0.29 per share for the year-ago quarter.

Total revenue was $1.1 million in the third quarter, compared to $1.0 million in the prior year quarter.

Analysts polled Thomson Reuters expected the company to report a loss of $0.33 per share on revenue of $360,000 for the third quarter.

Celldex said it expects its cash, cash equivalents and marketable securities to be sufficient to fund its operating expenses and capital expenditure requirements through 2016.